Ani Pharmaceuticals (ANIP) Return on Capital Employed Growth (1y) (2013 - 2026)
Ani Pharmaceuticals (ANIP) Return on Capital Employed Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn | 333.00 |
| 3 | Zoetis | 31.45 Bn | 29.77 Bn | 1.05 Bn | -469.00 |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 8.00 |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 220.00 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 802.00 |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 340.00 |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn | 573.00 |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn | 1,140.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,140.00 |
| Mar 31, 2026 | 979.00 |
| Dec 31, 2025 | 964.00 |
| Sep 30, 2025 | 523.00 |
| Jun 30, 2025 | -504.00 |
| Mar 31, 2025 | -683.00 |
| Dec 31, 2024 | -620.00 |
| Sep 30, 2024 | -440.00 |
| Jun 30, 2024 | 368.00 |
| Mar 31, 2024 | 840.00 |
| Dec 31, 2023 | 1,168.00 |
| Sep 30, 2023 | 1,485.00 |
| Jun 30, 2023 | 1,189.00 |
| Mar 31, 2023 | 817.00 |
| Dec 31, 2022 | 203.00 |
| Sep 30, 2022 | -513.00 |
| Jun 30, 2022 | -666.00 |
| Mar 31, 2022 | -779.00 |
| Dec 31, 2021 | -328.00 |
| Sep 30, 2021 | 138.00 |